Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xpress Genomics is a Swedish life science company specializing in high-throughput RNA sequencing technologies. Spun out from the Karolinska Institutet, the company leverages its proprietary Xpress-seq platform to enable scalable and cost-effective transcriptomics for drug discovery and functional genomics. Their technology automates the library preparation process, significantly reducing the time and cost associated with large-scale gene expression profiling. Xpress Genomics serves pharmaceutical companies and academic researchers looking to accelerate their research through high-resolution genomic data. The platform is designed to handle thousands of samples simultaneously, making it ideal for screening and longitudinal studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xpress Genomics.